Cerebral embolic protection devices during transcatheter aortic valve implantation, the current state of the art.
Sign Up to like & getrecommendations! Published in 2021 at "Acta cardiologica"
DOI: 10.1080/00015385.2021.1909276
Abstract: Stroke after transcatheter aortic valve (TAVI) is a devastating adverse event. The majority of these occur in the acute phase following TAVI where cerebral embolic events are frequent. Cerebral embolic protection devices (CEPD) have been… read more here.
Keywords: protection devices; embolic protection; cerebral embolic; aortic valve ... See more keywords
A randomized evaluation of the TriGuard™ HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trial.
Sign Up to like & getrecommendations! Published in 2021 at "European heart journal"
DOI: 10.1093/eurheartj/ehab213
Abstract: AIMS The REFLECT I trial investigated the safety and effectiveness of the TriGuard™ HDH (TG) cerebral embolic deflection device in patients undergoing transcatheter aortic valve replacement (TAVR). METHODS AND RESULTS This prospective, multicentre, single-blind, 2:1… read more here.
Keywords: cerebral embolic; aortic valve; triguard hdh; hdh cerebral ... See more keywords